Logo image of EXPI

EXP WORLD HOLDINGS INC (EXPI) Stock Fundamental Analysis

NASDAQ:EXPI - US30212W1009 - Common Stock

10.83 USD
+0.11 (+1.03%)
Last: 8/29/2025, 8:19:08 PM
11.04 USD
+0.21 (+1.94%)
After Hours: 8/29/2025, 8:19:08 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to EXPI. EXPI was compared to 63 industry peers in the Real Estate Management & Development industry. While EXPI has a great health rating, there are worries on its profitability. EXPI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXPI had negative earnings in the past year.
In the past year EXPI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: EXPI reported negative net income in multiple years.
EXPI had a positive operating cash flow in each of the past 5 years.
EXPI Yearly Net Income VS EBIT VS OCF VS FCFEXPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

EXPI's Return On Assets of -6.51% is on the low side compared to the rest of the industry. EXPI is outperformed by 61.90% of its industry peers.
With a Return On Equity value of -14.35%, EXPI perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
ROA -6.51%
ROE -14.35%
ROIC N/A
ROA(3y)-1.25%
ROA(5y)5.75%
ROE(3y)-2.62%
ROE(5y)10.13%
ROIC(3y)N/A
ROIC(5y)N/A
EXPI Yearly ROA, ROE, ROICEXPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

EXPI's Operating Margin has declined in the last couple of years.
EXPI's Gross Margin of 7.30% is on the low side compared to the rest of the industry. EXPI is outperformed by 76.19% of its industry peers.
EXPI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EXPI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.3%
OM growth 3Y-21.63%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
EXPI Yearly Profit, Operating, Gross MarginsEXPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

7

2. Health

2.1 Basic Checks

EXPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXPI has been reduced compared to 1 year ago.
EXPI has more shares outstanding than it did 5 years ago.
EXPI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXPI Yearly Shares OutstandingEXPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EXPI Yearly Total Debt VS Total AssetsEXPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EXPI has an Altman-Z score of 13.25. This indicates that EXPI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13.25, EXPI belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
There is no outstanding debt for EXPI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13.25
ROIC/WACCN/A
WACC8.86%
EXPI Yearly LT Debt VS Equity VS FCFEXPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

EXPI has a Current Ratio of 1.31. This is a normal value and indicates that EXPI is financially healthy and should not expect problems in meeting its short term obligations.
EXPI has a Current ratio of 1.31. This is comparable to the rest of the industry: EXPI outperforms 47.62% of its industry peers.
A Quick Ratio of 1.31 indicates that EXPI should not have too much problems paying its short term obligations.
EXPI has a Quick ratio (1.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
EXPI Yearly Current Assets VS Current LiabilitesEXPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

EXPI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -142.86%.
EXPI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.55%.
Measured over the past years, EXPI shows a very strong growth in Revenue. The Revenue has been growing by 36.05% on average per year.
EPS 1Y (TTM)-142.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.5%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%1.05%

3.2 Future

The Earnings Per Share is expected to grow by 38.90% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXPI will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-240%
EPS Next 2Y83.3%
EPS Next 3Y38.9%
EPS Next 5YN/A
Revenue Next Year3.07%
Revenue Next 2Y3.89%
Revenue Next 3Y3.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPI Yearly Revenue VS EstimatesEXPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
EXPI Yearly EPS VS EstimatesEXPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

3

4. Valuation

4.1 Price/Earnings Ratio

EXPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
EXPI is valuated quite expensively with a Price/Forward Earnings ratio of 265.44.
Based on the Price/Forward Earnings ratio, EXPI is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.72, EXPI is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 265.44
EXPI Price Earnings VS Forward Price EarningsEXPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

EXPI's Enterprise Value to EBITDA ratio is in line with the industry average.
87.30% of the companies in the same industry are more expensive than EXPI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.59
EV/EBITDA 2743.03
EXPI Per share dataEXPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

A more expensive valuation may be justified as EXPI's earnings are expected to grow with 38.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y83.3%
EPS Next 3Y38.9%

3

5. Dividend

5.1 Amount

EXPI has a Yearly Dividend Yield of 1.98%. Purely for dividend investing, there may be better candidates out there.
EXPI's Dividend Yield is rather good when compared to the industry average which is at 3.53. EXPI pays more dividend than 87.30% of the companies in the same industry.
EXPI's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

EXPI has been paying a dividend for over 5 years, so it has already some track record.
EXPI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
EXPI Yearly Dividends per shareEXPI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

EXPI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-96.95%
EPS Next 2Y83.3%
EPS Next 3Y38.9%
EXPI Yearly Income VS Free CF VS DividendEXPI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

EXP WORLD HOLDINGS INC

NASDAQ:EXPI (8/29/2025, 8:19:08 PM)

After market: 11.04 +0.21 (+1.94%)

10.83

+0.11 (+1.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-31 2025-07-31/dmh
Earnings (Next)11-05 2025-11-05/amc
Inst Owners38.77%
Inst Owner Change2.71%
Ins Owners43.16%
Ins Owner Change-0.34%
Market Cap1.70B
Analysts80
Price Target12.24 (13.02%)
Short Float %19.04%
Short Ratio15.42
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP-96.95%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-15 2025-08-15 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-521.45%
Min EPS beat(2)-928.9%
Max EPS beat(2)-114.01%
EPS beat(4)1
Avg EPS beat(4)-303.11%
Min EPS beat(4)-928.9%
Max EPS beat(4)48.1%
EPS beat(8)2
Avg EPS beat(8)-179.16%
EPS beat(12)3
Avg EPS beat(12)-122.65%
EPS beat(16)6
Avg EPS beat(16)-55.47%
Revenue beat(2)0
Avg Revenue beat(2)-3.64%
Min Revenue beat(2)-5.92%
Max Revenue beat(2)-1.37%
Revenue beat(4)1
Avg Revenue beat(4)-2.05%
Min Revenue beat(4)-5.92%
Max Revenue beat(4)4.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.58%
Revenue beat(12)5
Avg Revenue beat(12)-2.2%
Revenue beat(16)8
Avg Revenue beat(16)-0.66%
PT rev (1m)0%
PT rev (3m)-18.64%
EPS NQ rev (1m)-57.14%
EPS NQ rev (3m)-76.31%
EPS NY rev (1m)-500%
EPS NY rev (3m)-183.33%
Revenue NQ rev (1m)0.63%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)-1.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 265.44
P/S 0.37
P/FCF 13.59
P/OCF 12.57
P/B 7.8
P/tB 8.73
EV/EBITDA 2743.03
EPS(TTM)-0.17
EYN/A
EPS(NY)0.04
Fwd EY0.38%
FCF(TTM)0.8
FCFY7.36%
OCF(TTM)0.86
OCFY7.95%
SpS29.21
BVpS1.39
TBVpS1.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.51%
ROE -14.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.3%
FCFM 2.73%
ROA(3y)-1.25%
ROA(5y)5.75%
ROE(3y)-2.62%
ROE(5y)10.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.02%
ROCE(5y)9.77%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-21.63%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
F-Score4
Asset Turnover9.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 103.77%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion 23351.7%
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 13.25
F-Score4
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)91.01%
Cap/Depr(5y)129.15%
Cap/Sales(3y)0.21%
Cap/Sales(5y)0.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-142.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.5%
EPS Next Y-240%
EPS Next 2Y83.3%
EPS Next 3Y38.9%
EPS Next 5YN/A
Revenue 1Y (TTM)3.55%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%1.05%
Revenue Next Year3.07%
Revenue Next 2Y3.89%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y-2685.63%
EBIT growth 3Y-16.46%
EBIT growth 5YN/A
EBIT Next Year295.49%
EBIT Next 3Y72.68%
EBIT Next 5YN/A
FCF growth 1Y-34.32%
FCF growth 3Y-7.69%
FCF growth 5Y29.67%
OCF growth 1Y-32.08%
OCF growth 3Y-8.12%
OCF growth 5Y28.25%